Shares of InterMune (ITMN +7.8%) moves higher today on no significant news to speak of. One...
Friday, November 23, 2012, 12:42 PM ETShares of InterMune (ITMN +7.8%) moves higher today on no significant news to speak of. One positive catalyst could be from an article posted in Seeking Alpha late Wednesday rating the stock a Buy. The gist of the article is that, despite the risk of company being dependent on a single product - Esbriet - for growth, the company has thrown all its marketing resources behind its launch and expects it to yield a high payout for the effort.
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles